How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

US yields rise to multi-month highs on Trump's tariff threats
OMS Group inks deal with Ulstein for two next-generation cable-laying vessels
Ringgit firmer vs greenback on rising US-EU tensions
FBM KLCI retreats to 1,700 support as profit-taking accelerates
Trading ideas: IJM, Perak Corp, Kuchai, Favelle Favco, Reservoir Link, OpenSys, Teladan, PJBumi, AirAsia X, M&A Equity, Alliance Bank
AI boom deepens� global memory crunch�
Mixed outlook for Swift Haulage earnings potential
Rianlon Corp ups the ante in Johor
Japan bonds slump as food tax cut talk adds to election risk
EU weaponising US assets a risk, Deutsche Bank’s Saravelos says

Others Also Read